Biogen Inc. Files 8-K on Financials
Ticker: BIIB · Form: 8-K · Filed: Jul 7, 2025 · CIK: 875045
| Field | Detail |
|---|---|
| Company | Biogen Inc. (BIIB) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: BIIB
TL;DR
Biogen dropped an 8-K on July 7th covering financial results. Check it out.
AI Summary
Biogen Inc. filed an 8-K on July 7, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the report date and date of change both being July 7, 2025. Biogen Inc. is incorporated in Delaware and its principal executive offices are located at 225 Binney Street, Cambridge, Massachusetts.
Why It Matters
This 8-K filing provides an update on Biogen's financial condition and results of operations, which is crucial information for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Biogen Inc. (company) — Registrant
- July 7, 2025 (date) — Date of Report
- 225 Binney Street, Cambridge, Massachusetts (location) — Principal executive offices
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of the financial results are not provided in this excerpt.
When was this 8-K report filed?
The report was filed on July 7, 2025.
What is Biogen Inc.'s principal executive office address?
Biogen Inc.'s principal executive offices are located at 225 Binney Street, Cambridge, Massachusetts, 02142.
In which state is Biogen Inc. incorporated?
Biogen Inc. is incorporated in Delaware.
What is the SIC code for Biogen Inc.?
The Standard Industrial Classification (SIC) code for Biogen Inc. is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding BIOGEN INC. (BIIB).